All Releases All Releases MAR Regulatory Releases Selected Company Releases News Category AllAll ReleasesMAR Regulatory ReleasesSelected Company Releases Year All202620252024202320222021 Mar 16, 2026 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities Mar 13, 2026 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities Mar 11, 2026 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities Mar 6, 2026 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities Mar 5, 2026 Oculis Publishes 2025 Consolidated Financial Statements Mar 4, 2026 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities Mar 3, 2026 Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update Feb 27, 2026 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities Feb 18, 2026 Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated Jan 6, 2026 Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis
